Is brain amyloid production a cause or a result of dementia of the Alzheimer's type? - Test2 - elhamkhani - TriplyDB

Is brain amyloid production a cause or a result of dementia of the Alzheimer's type?

Is brain amyloid production a cause or a result of dementia of the Alzheimer's type?

http://www.wikidata.org/entity/Q34814013

about

Temperature and toxic Tau in Alzheimer's disease: new insights Preventing Alzheimer's disease by means of natural selection γ-secretase binding sites in aged and Alzheimer's disease human cerebrum: the choroid plexus as a putative origin of CSF Aβ Chronic temporal lobe epilepsy is associated with enhanced Alzheimer-like neuropathology in 3×Tg-AD mice Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice.Bioenergetics breakdown in Alzheimer's disease: targets for new therapies Systematic review of the relationship between amyloid-β levels and measures of transgenic mouse cognitive deficit in Alzheimer's disease.Amyloid accumulation is a late event in sporadic Alzheimer's disease-like pathology in nontransgenic rats.Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies.BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology.The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain.Experimental microembolism induces localized neuritic pathology in guinea pig cerebrum.Amyloid plaque pathogenesis in 5XFAD mouse spinal cord: retrograde transneuronal modulation after peripheral nerve injury Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.Imaging the Alzheimer brain.Can BACE1 inhibition mitigate early axonal pathology in neurological diseases?Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease.Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer's Disease and Other Neurodegenerative Diseases.Angelica sinensis reduced Aβ-induced memory impairment in rats.Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients.Rhinacanthin C Alleviates Amyloid-β Fibrils' Toxicity on Neurons and Attenuates Neuroinflammation Triggered by LPS, Amyloid-β, and Interferon-γ in Glial Cells.Hydrogen Sulfide Selectively Inhibits γ-Secretase Activity and Decreases Mitochondrial Aβ Production in Neurons from APP/PS1 Transgenic Mice.Amyloid-related imaging abnormalities associated with immunotherapy in Alzheimer’s disease patients

P2860

Q26745778-752F0CB8-CF04-4766-BBA1-CD335609F08D Q28088701-579D8A70-93D9-41DC-BC7C-6BAF2F63FB94 Q28687678-98276014-EC91-482B-A6B6-8D5EDFCD26BE Q34479091-61270266-22A0-4F4A-87E4-DD0B6623D0E8 Q34656871-4E643D85-B3EE-4A4D-8306-DA5F4C8673C8 Q35098445-7861FACA-1CE4-4E22-8DA3-503AB8FB3A6C Q35137134-CC8F9AB0-7A38-4D2C-B5C9-46142A7789A1 Q35176315-2E24BD7A-E042-4A2F-B14A-467C546697C3 Q35231770-75227AA1-3D2E-418B-820A-DFA0E113F5C8 Q35583236-25BC0A5D-3C89-4263-821E-B39E64CD64E9 Q35599843-0F4DE7C6-3C07-4746-989B-B8C6CAF9C059 Q35793607-A71C3D4F-2FB3-4170-BFC3-8A47F1C7070E Q36586319-4C966DEC-9D9F-455D-8F87-63C6B680E3D4 Q37102001-3752DDD5-F310-450B-94D6-EDB4A0122407 Q37141502-E48701D1-72BF-4788-8DBF-5E767F420030 Q37715869-E56711AB-80D0-44EC-BBE1-2AEC3780BEC7 Q37999086-0339BD92-051B-4236-95AA-3BBB3B86316C Q38668948-26224578-91AF-4201-8DFE-305D82E4D07B Q38798611-0AC0B77D-EFBA-4FE6-912C-803AA4258C60 Q38966308-F0E00CD0-FC16-430F-93EA-2DC34F499E6C Q47104106-8B110ED1-C040-41CF-9BEC-7A1CD682548D Q49093504-136A73C6-D3A7-4C32-A77D-088D21156347 Q58005714-84F85C49-4ABD-435B-8215-1204A01F91F2

P2860

Is brain amyloid production a cause or a result of dementia of the Alzheimer's type?

http://www.wikidata.org/entity/Q34814013

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Is brain amyloid production a cause or a result of dementia of the Alzheimer's type?

@ast

Is brain amyloid production a cause or a result of dementia of the Alzheimer's type?

@en

Is brain amyloid production a cause or a result of dementia of the Alzheimer's type?

@nl

type

label

Is brain amyloid production a cause or a result of dementia of the Alzheimer's type?

@ast

Is brain amyloid production a cause or a result of dementia of the Alzheimer's type?

@en

Is brain amyloid production a cause or a result of dementia of the Alzheimer's type?

@nl

prefLabel

Is brain amyloid production a cause or a result of dementia of the Alzheimer's type?

@ast

Is brain amyloid production a cause or a result of dementia of the Alzheimer's type?

@en

Is brain amyloid production a cause or a result of dementia of the Alzheimer's type?

@nl

P1433

Q34814013-943C7B98-4175-4520-8863-90FDAC7E7381

P1476

Q34814013-38AAC60B-1D93-472D-91DA-CCEBB2DC74BE

P2093

Q34814013-69370D49-BCD2-48B1-A143-E002F4D803BD

Q34814013-69AF6B25-072F-427A-83B1-726E28F580B7

Q34814013-CA04DC27-5F3D-4F85-86B0-81F1C753B041

Q34814013-CD705348-D6E4-483C-A36B-47F27867B7E9

Q34814013-D99C2D3E-9D6D-4CFA-947F-F9AA5367080A

P2860

Q34814013-09D33305-7F29-47B6-9731-3E6383CD601B

Q34814013-0AA7AE7A-F1B3-4527-AF57-C4EEC619F589

Q34814013-137DCF72-54A4-46A0-A449-22D78680A4D2

Q34814013-165F3B1D-35D1-4F6E-BE81-14760997DBD0

Q34814013-18A822A3-DF17-48D9-AE59-E759C76CFDD4

Q34814013-1A72AC95-362B-4AAE-ADB3-209AF1F2A973

Q34814013-1C2A3F6F-EA2D-4A75-9ED7-E824089C9B54

Q34814013-1D758574-710F-44C0-9BCA-E3620F575D32

Q34814013-1DA5C2FA-0E0C-47DE-8589-16725DC5CF14

Q34814013-1F38450E-635D-47BA-A423-89BAEA923DF1

P304

Q34814013-0599AB76-B75A-4DAA-B806-16AE3D9D135F

P31

Q34814013-3FD73017-54A3-4B6B-A772-368CB4C60F41

P356

Q34814013-2A2FEA66-2FF5-4BA7-BFC8-96F1A87DCBCA

P433

Q34814013-4468710A-2D6A-48E4-AEBD-7AC73D264505

P478

Q34814013-B72B5D0D-39E9-430B-8F6E-5300F433F0E6

P577

Q34814013-A9B1A06A-FB23-47FB-973F-B1FAD5A1F3F9

P698

Q34814013-AA534769-B57C-45CB-8B08-F7D86A9F4804

P921

Q34814013-58E2332F-A209-4D4B-909D-3E09DF5FB4A4

P932

Q34814013-99AC5A67-39C1-497A-8768-EF9CB41A6367

P356

JAD-2010-100846

P1433

Journal of Alzheimer's Disease

P1476

Is brain amyloid production a cause or a result of dementia of the Alzheimer's type?

@en

P2093

Gregory J Brewer

http://www.w3.org/2001/XMLSchema#string

Peter R Patrylo

http://www.w3.org/2001/XMLSchema#string

Robert G Struble

http://www.w3.org/2001/XMLSchema#string

Tom Ala

http://www.w3.org/2001/XMLSchema#string

Xiao-Xin Yan

http://www.w3.org/2001/XMLSchema#string

P2860

Imaging correlates of brain function in monkeys and rats isolates a hippocampal subregion differentially vulnerable to aging

Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior

The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study

Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus.

Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment

An energy budget for signaling in the grey matter of the brain

Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations

Epigenetic oxidative redox shift (EORS) theory of aging unifies the free radical and insulin signaling theories.

Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development

Cerebral blood flow and metabolism during exercise.

P304

393-399

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-2010-100846

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20847431

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3079347

http://www.w3.org/2001/XMLSchema#string